how often should you microdose tirzepatide Microdosing GLP-1s: Safety, Dosage, Side Effects, and Results Microdosing Tirzepatide + Glycine Product

Neurology 32:13301334

also observed similar phenomena in the testes of STZ-induced diabetic mice and HG-treated GC-1spg cells, and found that BRD7 inhibits Clusterin expression by regulating hypermethylation of the Clusterin promoter in an EZH2-dependent manner, thereby suppressing AMPK signaling to promote ferroptosis and induce DM-related testicular injury [178]

Most guidelines recommend stopping GLP-1 medications at least two months before planned conception

Mats Christian Hjbjerg Lassen, John W

If you're considering GLP-1 therapy, understanding your medical history, metabolic health, and risk factors is just as important as choosing the medication itself